![Makoto Inoue](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Makoto Inoue
Direktor/Vorstandsmitglied bei Id Pharma Co., Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Toyotaka Mori | M | 65 |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 10 Jahre |
Tsugumine Shu | M | 66 |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 Jahre |
Kiyomi Kindaichi | F | 61 |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 15 Jahre |
Kunikatsu Shirahata | M | - |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | 20 Jahre |
Yoshikazu Yonemitsu | M | 61 |
Kyushu University
| 34 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Masaharu Inoue | M | 62 |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Yohei Tanida | M | 62 |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Kyohei Morita | M | - |
Kyushu University
| 4 Jahre |
Soushi Ikeda | M | 56 |
Kyushu University
| 4 Jahre |
Shiro Toba | M | 57 |
Id Pharma Co., Ltd.
![]() Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | - |
Jian Ding | M | 71 |
Kyushu University
| 3 Jahre |
Huai Dong Wang | M | 59 |
Kyushu University
| 3 Jahre |
Masanori Yoshitake | M | 51 |
Kyushu University
| 4 Jahre |
Michitaka Goto | M | 58 |
Kyushu University
| 4 Jahre |
Xiang Dong He | M | 61 |
Kyushu University
| 3 Jahre |
Hideo Umeki | M | 60 |
Kyushu University
| 4 Jahre |
Shigeru Nakashima | M | - |
Kyushu University
| 4 Jahre |
Mohammad Shafiq | M | 63 |
Kyushu University
| 3 Jahre |
Shinya Tamura | M | 57 |
Kyushu University
| 2 Jahre |
Rui Ping Dong | M | 62 |
Kyushu University
| 3 Jahre |
Tetsuo Mitsuyasu | M | - |
Kyushu University
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Japan | 21 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Makoto Inoue
- Persönliches Netzwerk